Skip to Main Content

Hello, everyone, and how are you today? We are doing just fine, thank you, with help from a delightfully shiny sun enveloping the Pharmalot campus and a few needed cups of stimulation. Our flavor today is Cinnamon Dolce, for those keeping track. Meanwhile, here is the usual lineup of tidbits. We should note, by the way, that we will be taking an extended weekend and colleagues will fill in for us. On that note, have a wonderful few days and see you soon …

AstraZeneca employed a man in Australia who allegedly falsified his credentials and posed as a doctor who was from India, ABC reports. Shyyam Acharya gained registration with the Medical Board of New South Wales in 2003 and, later, worked for the drug maker for 11 months from 2013 to 2014. The drug makers says that “his stated overseas medical qualification was not a core requirement of the role therefore was not investigated at the time.”


After President Trump met with Rep. Elijah Cummings (D-Md.) Wednesday, a bill to allow Medicare to negotiate drug prices may be put forward in Congress within two or three weeks, STAT tells us. The bill would direct the secretary of the Department of Health and Human Services to begin negotiations with drug makers that participate in Medicare. The full text is not available, but you can read a summary here.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!